TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
Center for Lymphoid Malignancies
Curated by ChEMBL
Center for Lymphoid Malignancies
Curated by ChEMBL
Affinity DataIC50: 6.70nMAssay Description:Inhibition of human RIPK2 using myelin basic protein as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 12...More data for this Ligand-Target Pair

3D Structure (crystal)